15th Annual University of Pennsylvania conference on statistical issues in clinical trial/advances in time to event analyses in clinical trials (morning panel discussion)

Mehrotra DV West RM . Survival analysis using a 5-step stratified testing and amalgamation routine (5-STAR) in randomized clinical trials. Stat Med 2020; 39(30): 4724–4744.

Mukhopadhyay P Ye J Anderson KM , et al. Log-rank test vs MaxCombo and difference in restricted mean survival time tests for comparing survival under nonproportional hazards in immuno-oncology trials: a systematic review and meta-analysis. JAMA Oncol 2022; 8(9): 1294–1300.

Lin DY Sun W Ying Z . Nonparametric estimation of the gap time distribution for serial events with censored data. Biometrika 1999; 86(1): 59–70.

Xu Z Zhen B Park Y , et al. Designing therapeutic cancer vaccine trials with delayed treatment effect. Stat Med 2017; 36(4): 592–605.

Martinussen T . Causality and the Cox regression model. Annu Rev Stat Appl 2022; 9: 249–259.

Martinussen T Vansteelandt S Andersen PK . Subtleties in the interpretation of hazard contrasts. Lifetime Data Anal 2020; 26(4): 833–855.

Huang Y Louis TA . Nonparametric estimation of the joint distribution of survival time and mark variables. Biometrika 1998; 85(4): 785–798.

Prentice RL Williams BJ Peterson AV . On the regression analysis of multivariate failure time data. Biometrika 1981; 68(2): 373–379.

Wei LJ Lin DY Weissfeld L . Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989; 84(408): 1065–1073.

Pocock SJ Ariti CA Collier TJ , et al. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J 2012; 33(2): 176–182.

Claggett BL McCaw ZR Tian L , et al. Quantifying treatment effects in trials with multiple event-time outcomes. NEJM Evid 2022; 1(10): 10.1056/evidoa2200047.

Luo X Tian H Mohanty S , et al. An alternative approach to confidence interval estimation for the win ratio statistic. Biometrics 2015; 71(1): 139–145.

Mao L . On causal estimation using U-statistics. Biometrika 2018; 105(1): 215–220.

Mao L . On the alternative hypotheses for the win ratio. Biometrics 2019; 75(1): 347–351.

Xu Z Park Y Zhen B , et al. Designing cancer immunotherapy trials with random treatment time-lag effect. Stat Med 2018; 37(30): 4589–4609.

Therneau TM Grambsch PM . Testing proportional hazards. In: Modeling survival data: Extending the Cox Model. Statistics for Biology and Health. New York: Springer, 2000.